Results 271 to 280 of about 143,284 (315)

The coagulome of Head and Neck Squamous Cell Carcinoma

Oral Oncology, 2021
International ...
Zuzana Saidak, Antoine Galmiche, Marine Lottin, Lydia Montes, Simon Soudet, Marie-Antoinette Sevestre, Florian Clatot, Haitham Mirghani   +7 more
openaire   +3 more sources

Squamous Cell Carcinoma of the Head and Neck in the Elderly

Archives of Otolaryngology - Head and Neck Surgery, 1995
While squamous cell carcinoma of the head and neck (HNSCC) most commonly affects individuals in the fifth to seventh decades of life, it occasionally arises in older patients. Biologic and epidemiologic factors of HNSCC in elderly patients have been investigated to shed light on the process of neoplastic transformation in that population.The medical ...
W M, Koch, H, Patel, J, Brennan, J O, Boyle, D, Sidransky   +4 more
openaire   +2 more sources

Oligometastasis in Head and Neck Squamous Cell Carcinoma

International Journal of Radiation Oncology*Biology*Physics, 2022
Up to 40% of patients who present with, or later develop, metastatic disease from head and neck squamous cell carcinoma have oligometastatic disease, defined as 5 or fewer sites of metastasis. Patients with limited number of metastases clearly have improved overall survival compared with those with more disseminated metastases, but the risk of, and ...
Dominic H, Moon, David J, Sher
openaire   +2 more sources

Hypercalcemia in Head and Neck Squamous-Cell Carcinoma

American Journal of Clinical Oncology, 1990
Hypercalcemia was previously considered a terminal phenomenon in advanced head and neck squamous-cell carcinoma. We report on six patients with head and neck carcinoma and hypercalcemia refractory to conventional measures. Three patients had stage IV tumor not amenable to surgery or radiation therapy and three others had carcinoma recurrent after ...
K S, Sridhar, A M, Hussein
openaire   +2 more sources

Chemoprevention of squamous cell carcinoma of the head and neck

Current Opinion in Oncology, 2007
The aim of this article is to summarize progress in understanding of the biology of squamous cell carcinoma of the head and neck and of trials to prevent malignant conversion of oral premalignant lesions and the development of second primary tumors in those already treated for squamous cell carcinoma of the head and neck.The understanding of squamous ...
John M, Wrangle, Fadlo R, Khuri
openaire   +2 more sources

Squamous cell carcinoma of the head and neck in children

International Journal of Pediatric Otorhinolaryngology, 2019
To discuss the presentation, evaluation, and management of squamous cell carcinoma of the head and neck in the pediatric population.Medical records of pediatric (≤20 years) patients treated for squamous cell carcinoma of the head and neck between 1996 and 2016 were reviewed.
Natasha D. Dombrowski, Nikolaus E. Wolter, Alexandria L. Irace, Caroline D. Robson, Antonio R. Perez-Atayde, Jennifer W. Mack, Reza Rahbar   +6 more
openaire   +2 more sources

Afatinib in squamous cell carcinoma of the head and neck

Expert Opinion on Pharmacotherapy, 2016
Recently new data on the efficacy of afatinib in head and neck squamous cell carcinoma (HNSCC) have been published.We searched the literature for published and ongoing studies with afatinib in HNSCC. Phase I data and results of phase II and III studies of afatinib in HNSCC are discussed.
Specenier, Pol, Vermorken, Jan
openaire   +3 more sources

Head and neck squamous cell carcinoma in childhood

Medical and Pediatric Oncology, 1998
Squamous cell carcinoma (SCC) of the head and neck region is rare in young patients and even less frequent in children 15 years or younger children. The patients reported in the literature are isolated cases and their management is always difficult because there is no large experience or a convincing theory to support treatment decisions for every ...
M B, de Carvalho, J de A, Sobrinho, A, Rapoport, A S, Fava, A F, Mendes, J L, Kanda, C N, Lehn, J, Chacra Júnior, M B, Menezes, F, Walder, S A, Franzi   +10 more
openaire   +2 more sources

Cetuximab In Squamous Cell Carcinoma of the Head and Neck

Future Oncology, 2006
Surgery and radiotherapy are the standard treatment options for patients with squamous cell carcinoma of the head and neck (SCCHN). Chemotherapy and chemoradiotherapy are new alternatives for locally advanced disease, particularly induction chemotherapy for patients with unresectable tumors.
Ricardo, Hitt, Patricia, Martín, Manuel, Hidalgo   +2 more
openaire   +2 more sources

Basaloid squamous cell carcinoma of the head and neck

Current Opinion in Otolaryngology & Head and Neck Surgery, 2004
Basaloid squamous cell carcinoma is an uncommon variant of squamous cell carcinoma and was first described as a distinct entity in 1986. Basaloid squamous cell carcinoma seems to have a poorer survival rate than classical squamous cell carcinoma. On the basis of a critical literature survey, we attempt to evaluate if basaloid squamous cell carcinoma is
Zbären P, Nuyens M, Stauffer E
openaire   +3 more sources